Watlow launches LEGACY SERIES Panel-mount Temperature Controllers
Watlow® has introduced its new LEGACY SERIES Panel-mount Temperature Controllers, which offer simple menus and are perfectly suited for basic
Read more
Press Releases
BioMed Raises $177M to Accelerate Next-Gen Biologics Development
Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,
Read more
Nubilaria ACTide to attend BIO Digital International Convention
With collaboration being more important now than ever before, Nubilaria ACTide will attend BIO Digital to be a part of
Read more
AbbVie and BioMed to develop monoclonal antibody for COVID-19
AbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read more
Watlow Launches Batch Processing for Thermal Data Controller and Data Logger
Watlow, an industry pioneer in the design and manufacture of complete thermal systems, has recently launched a batch processing feature
Read more
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
FDA clears Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for GIST
Deciphera Pharmaceuticals, Inc. has revealed that QINLOCK™ (ripretinib) was formally authorised by the U.S. Food and Drug Administration (FDA) for
Read more
Metrohm unveils new modular 2060 Process Analyzer
The new 2060 Process Analyzer by Metrohm Process Analytics offers customized online monitoring of critical chemical parameters in industrial processes
Read more
Join Nubilaria ACTide at the OCT 2020 virtual conference
Nubilaria ACTide will attend the Outsourcing in Clinical Trials 2020 virtual conference hosted by Arena International. The unique one-day global
Read more
Shionogi receives EC approval for new antibiotic FETCROJA® (cefiderocol)
Japanese research-driven pharmaceutical company Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. announced on April 28 that the
Read more